Copyright Reports & Markets. All rights reserved.

Global Advanced Parenteral Drug Delivery Devices Market Research Report 2021

Buy now

1 Advanced Parenteral Drug Delivery Devices Market Overview

  • 1.1 Product Overview and Scope of Advanced Parenteral Drug Delivery Devices
  • 1.2 Advanced Parenteral Drug Delivery Devices Segment by Type
    • 1.2.1 Global Advanced Parenteral Drug Delivery Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Prefillable Syringes
    • 1.2.3 IV Catheters
    • 1.2.4 Vial Bag Infusion Systems
    • 1.2.5 Hypodermic Syringes
    • 1.2.6 Other Parenteral Delivery Devices
  • 1.3 Advanced Parenteral Drug Delivery Devices Segment by Application
    • 1.3.1 Advanced Parenteral Drug Delivery Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 ASCs
    • 1.3.5 Others
  • 1.4 Global Advanced Parenteral Drug Delivery Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Advanced Parenteral Drug Delivery Devices Revenue 2016-2027
    • 1.4.2 Global Advanced Parenteral Drug Delivery Devices Sales 2016-2027
    • 1.4.3 Advanced Parenteral Drug Delivery Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Advanced Parenteral Drug Delivery Devices Market Competition by Manufacturers

  • 2.1 Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Advanced Parenteral Drug Delivery Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Advanced Parenteral Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Advanced Parenteral Drug Delivery Devices Market Competitive Situation and Trends
    • 2.5.1 Advanced Parenteral Drug Delivery Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Advanced Parenteral Drug Delivery Devices Players Market Share by Revenue
    • 2.5.3 Global Advanced Parenteral Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Advanced Parenteral Drug Delivery Devices Retrospective Market Scenario by Region

  • 3.1 Global Advanced Parenteral Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Advanced Parenteral Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Advanced Parenteral Drug Delivery Devices Market Facts & Figures by Country
    • 3.3.1 North America Advanced Parenteral Drug Delivery Devices Sales by Country
    • 3.3.2 North America Advanced Parenteral Drug Delivery Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Advanced Parenteral Drug Delivery Devices Market Facts & Figures by Country
    • 3.4.1 Europe Advanced Parenteral Drug Delivery Devices Sales by Country
    • 3.4.2 Europe Advanced Parenteral Drug Delivery Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Advanced Parenteral Drug Delivery Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Advanced Parenteral Drug Delivery Devices Sales by Region
    • 3.5.2 Asia Pacific Advanced Parenteral Drug Delivery Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Advanced Parenteral Drug Delivery Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Advanced Parenteral Drug Delivery Devices Sales by Country
    • 3.6.2 Latin America Advanced Parenteral Drug Delivery Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Advanced Parenteral Drug Delivery Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Advanced Parenteral Drug Delivery Devices Sales by Country
    • 3.7.2 Middle East and Africa Advanced Parenteral Drug Delivery Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Advanced Parenteral Drug Delivery Devices Historic Market Analysis by Type

  • 4.1 Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Advanced Parenteral Drug Delivery Devices Price by Type (2016-2021)

5 Global Advanced Parenteral Drug Delivery Devices Historic Market Analysis by Application

  • 5.1 Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Advanced Parenteral Drug Delivery Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Abbott Laboratories
    • 6.1.1 Abbott Laboratories Corporation Information
    • 6.1.2 Abbott Laboratories Description and Business Overview
    • 6.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Abbott Laboratories Product Portfolio
    • 6.1.5 Abbott Laboratories Recent Developments/Updates
  • 6.2 Amgen
    • 6.2.1 Amgen Corporation Information
    • 6.2.2 Amgen Description and Business Overview
    • 6.2.3 Amgen Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Amgen Product Portfolio
    • 6.2.5 Amgen Recent Developments/Updates
  • 6.3 Pfizer
    • 6.3.1 Pfizer Corporation Information
    • 6.3.2 Pfizer Description and Business Overview
    • 6.3.3 Pfizer Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Pfizer Product Portfolio
    • 6.3.5 Pfizer Recent Developments/Updates
  • 6.4 Roche
    • 6.4.1 Roche Corporation Information
    • 6.4.2 Roche Description and Business Overview
    • 6.4.3 Roche Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Roche Product Portfolio
    • 6.4.5 Roche Recent Developments/Updates
  • 6.5 AstraZeneca
    • 6.5.1 AstraZeneca Corporation Information
    • 6.5.2 AstraZeneca Description and Business Overview
    • 6.5.3 AstraZeneca Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 AstraZeneca Product Portfolio
    • 6.5.5 AstraZeneca Recent Developments/Updates
  • 6.6 BD
    • 6.6.1 BD Corporation Information
    • 6.6.2 BD Description and Business Overview
    • 6.6.3 BD Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 BD Product Portfolio
    • 6.6.5 BD Recent Developments/Updates
  • 6.7 Boston Scientific
    • 6.6.1 Boston Scientific Corporation Information
    • 6.6.2 Boston Scientific Description and Business Overview
    • 6.6.3 Boston Scientific Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Boston Scientific Product Portfolio
    • 6.7.5 Boston Scientific Recent Developments/Updates
  • 6.8 Bristol-Myers Squibb
    • 6.8.1 Bristol-Myers Squibb Corporation Information
    • 6.8.2 Bristol-Myers Squibb Description and Business Overview
    • 6.8.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Bristol-Myers Squibb Product Portfolio
    • 6.8.5 Bristol-Myers Squibb Recent Developments/Updates
  • 6.9 GSK
    • 6.9.1 GSK Corporation Information
    • 6.9.2 GSK Description and Business Overview
    • 6.9.3 GSK Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 GSK Product Portfolio
    • 6.9.5 GSK Recent Developments/Updates
  • 6.10 Novartis
    • 6.10.1 Novartis Corporation Information
    • 6.10.2 Novartis Description and Business Overview
    • 6.10.3 Novartis Advanced Parenteral Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Novartis Product Portfolio
    • 6.10.5 Novartis Recent Developments/Updates

7 Advanced Parenteral Drug Delivery Devices Manufacturing Cost Analysis

  • 7.1 Advanced Parenteral Drug Delivery Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Advanced Parenteral Drug Delivery Devices
  • 7.4 Advanced Parenteral Drug Delivery Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Advanced Parenteral Drug Delivery Devices Distributors List
  • 8.3 Advanced Parenteral Drug Delivery Devices Customers

9 Advanced Parenteral Drug Delivery Devices Market Dynamics

  • 9.1 Advanced Parenteral Drug Delivery Devices Industry Trends
  • 9.2 Advanced Parenteral Drug Delivery Devices Growth Drivers
  • 9.3 Advanced Parenteral Drug Delivery Devices Market Challenges
  • 9.4 Advanced Parenteral Drug Delivery Devices Market Restraints

10 Global Market Forecast

  • 10.1 Advanced Parenteral Drug Delivery Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Advanced Parenteral Drug Delivery Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Advanced Parenteral Drug Delivery Devices by Type (2022-2027)
  • 10.2 Advanced Parenteral Drug Delivery Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Advanced Parenteral Drug Delivery Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Advanced Parenteral Drug Delivery Devices by Application (2022-2027)
  • 10.3 Advanced Parenteral Drug Delivery Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Advanced Parenteral Drug Delivery Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Advanced Parenteral Drug Delivery Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Prefillable Syringes
    IV Catheters
    Vial Bag Infusion Systems
    Hypodermic Syringes
    Other Parenteral Delivery Devices

    Segment by Application
    Hospitals
    Clinics
    ASCs
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Abbott Laboratories
    Amgen
    Pfizer
    Roche
    AstraZeneca
    BD
    Boston Scientific
    Bristol-Myers Squibb
    GSK
    Novartis

    Buy now